ALG10 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84420
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of Human ALG10. Peptide sequence: AVFCAGNVIAQKLTEAWKTELQKKEDRLPPIKGPFAEFRKILQFLLAYSM The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for ALG10 Antibody
Western Blot: ALG10 Antibody [NBP2-84420]
Western Blot: ALG10 Antibody [NBP2-84420] - WB Suggested Anti-ALG10 Antibody. Titration: 1.0 ug/ml. Positive Control: PlacentaApplications for ALG10 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ALG10
Alternate Names
ALG10A, alpha-1,2-glucosyltransferase ALG10-A, alpha-1,2-glucosyltransferase), alpha2-glucosyltransferase, Alpha-2-glucosyltransferase ALG10-A, asparagine-linked glycosylation 10 homolog (yeast, asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S.pombe), asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog(yeast), Asparagine-linked glycosylation protein 10 homolog A, derepression of ITR1 expression 2 homolog, DIE2, EC 2.4.1, EC 2.4.1.-, EC 2.4.1.16, FLJ14751, KCR1, potassium channel regulator 1
Gene Symbol
ALG10
Additional ALG10 Products
Product Specific Notices for ALG10 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...